| Literature DB >> 21436172 |
Margaret Clarke1, Eduardo da Cruz2, Julianne Koehler2, Jon Kaufman3.
Abstract
Heparin prophylaxis (HP) is commonly used for prevention of central venous catheter (CVC)-related complications among pediatric intensivists, yet efficacy of this therapy is unknown. We conducted a survey of pediatric intensivists and their experiences with HP. A total of 96 responses were received. Almost half of the respondents regularly used HP in patients with CVCs, yet most were unsure of its benefit. The majority of respondents claimed to experience no adverse effects; the complications that were reported to occur were related to bleeding or suspected heparin-induced thrombocytopenia (HIT). Overall, participants felt CVC-associated HP was safe in pediatric critical illness, while acknowledging the paucity of compelling data. © SAGE Publications 2011.Entities:
Keywords: heparin prophylaxis; pediatric critical illness; thrombosis central venous catheters
Mesh:
Substances:
Year: 2011 PMID: 21436172 DOI: 10.1177/0885066610392501
Source DB: PubMed Journal: J Intensive Care Med ISSN: 0885-0666 Impact factor: 3.510